Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

doi:10.3748/wjg.v25.i25.3151

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15366)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

1020

WORD

177

HTML

9890

Figures (1-4)

500

Tables (1-1)

264

Sum=11851

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

512

Download

768

Sum=1280

Publishing Process of This Article

Item

Count

Browse

857

Download

1378

Sum=2235

Jul 7, 2019 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (87)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 7, 2019; 25(25): 3151-3167
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3151

Full Size Figure Download Figure

Figure 2 STAT3 signaling contributes to form an immunosuppressive microenvironment in hepatocellular carcinoma. Long lines ending with arrows or bars indicate activating or inhibitory effects, respectively. Short arrows pointing up or down indicate up-regulated or down-regulated, respectively. TAMs: Tumor-associated macrophages; CAFs: Cancer-associated fibroblasts; NK cell: Natural killer cell; DCs: Dendritic cells; NE: Neutrophil elastase; HCC: Hepatocellular carcinoma.

Citation: Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167
URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3151.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i25.3151